Correlation Between Korean Drug and Xavis
Can any of the company-specific risk be diversified away by investing in both Korean Drug and Xavis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korean Drug and Xavis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Korean Drug Co and Xavis Co, you can compare the effects of market volatilities on Korean Drug and Xavis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korean Drug with a short position of Xavis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korean Drug and Xavis.
Diversification Opportunities for Korean Drug and Xavis
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Korean and Xavis is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Korean Drug Co and Xavis Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xavis and Korean Drug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korean Drug Co are associated (or correlated) with Xavis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xavis has no effect on the direction of Korean Drug i.e., Korean Drug and Xavis go up and down completely randomly.
Pair Corralation between Korean Drug and Xavis
Assuming the 90 days trading horizon Korean Drug Co is expected to generate 0.87 times more return on investment than Xavis. However, Korean Drug Co is 1.15 times less risky than Xavis. It trades about 0.04 of its potential returns per unit of risk. Xavis Co is currently generating about -0.18 per unit of risk. If you would invest 468,069 in Korean Drug Co on October 24, 2024 and sell it today you would earn a total of 20,931 from holding Korean Drug Co or generate 4.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Korean Drug Co vs. Xavis Co
Performance |
| Timeline |
| Korean Drug |
| Xavis |
Korean Drug and Xavis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Korean Drug and Xavis
The main advantage of trading using opposite Korean Drug and Xavis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korean Drug position performs unexpectedly, Xavis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xavis will offset losses from the drop in Xavis' long position.| Korean Drug vs. Kolon Life Science | Korean Drug vs. JETEMA Co | Korean Drug vs. Aminologics CoLtd | Korean Drug vs. Daihan Pharmaceutical CoLtd |
| Xavis vs. KakaoBank Corp | Xavis vs. Dgb Financial | Xavis vs. Koryo Credit Information | Xavis vs. Korean Drug Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |